This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H3N2 Hemagglutinin (HA)
Product Overview
BioVenic's Recombinant Influenza A H3N2 Hemagglutinin (HA) is a recombinant protein expressed from Baculovirus-insect cell. Its predicted molecular weight is 61.9 kDa. The purity is>85% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
Influenza A virus subtype H3N2 (A/H3N2) is a strain that causes the flu and can infect both birds and mammals. This virus evolves continuously, with high genetic variation in its hemagglutinin (HA) and neuraminidase (NA) genes due to antigenic drift.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- Anoma, Sasiprapa, Parvapan Bhattarakosol, and Ekasit Kowitdamrong. "Characteristics and evolution of hemagglutinin and neuraminidase genes of Influenza A (H3N2) viruses in Thailand during 2015 to 2018." PeerJ 12 (2024): e17523.